BRS & Co. Sells Organika Health Products, Inc.

May 21, 2024

New York – May 21, 2024 – BRS & Co. (“BRS”), a New York-based private equity firm, announced the sale of Organika Health Products, Inc. (“Organika” or the “Company”) in a management buyout by the family who founded the Company.

The Company, based in Vancouver, British Columbia, is a marketer of Organika branded nutritional supplements and many other products supporting health and beauty.  During BRS’s investment period, Organika continued a high pace of product innovation and significantly expanded its retail distribution. 

Aaron Chin, Organika’s CEO, said, “We are very excited for the future and thank BRS for their support.” 

Rashad Rahman, BRS Managing Director, said, “We are pleased to be returning Organika to the Chin family and wish them continued success.”

About BRS & Co.

BRS is a New York-based private equity investment firm with a combined capital invested of $1.2 billion, focused on investing in lower middle market consumer goods and services businesses. Since 1996, BRS has purchased over 50 portfolio companies for aggregate consideration of over $6.9 billion. In addition, BRS portfolio companies have completed over 40 add-on acquisitions. For more information, please visit